CATALYST PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Offer Letter between the Company and Michael W. Kalb (Filed With SEC on February 28, 2024)
- Offer Letter between the Company and Richard J. Daly (Filed With SEC on February 28, 2024)
- Amendment No. 2 to Rights Agreement, dated as of August 28, 2019, between Catalyst Pharmaceuticals, Inc. and Continental Stock Transfer and Trust Company, as Rights Agent (Filed With SEC on August 30, 2019)
- Amendment No. 1 to Collaborative Agreement with Endo for generic Sabril (certain identified information has been excluded from this exhibit because it is both (i) not material and... (Filed With SEC on May 10, 2019)
- AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on September 20, 2016)
- [To be separately provided to the Investor] (Filed With SEC on September 5, 2013)
- [To be separately provided to the Investor] (Filed With SEC on August 28, 2012)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on October 2, 2009)
- Catalyst Pharmaceutical Partners, Inc. 355 Alhambra Circle Suite 1370 Coral Gables, Florida 33134 (Filed With SEC on December 23, 2008)
- Ex-10.1 Engagement Letter (Filed With SEC on September 12, 2008)
- EX-10.14 Agreement with Pharmaceutics International Inc (Filed With SEC on September 1, 2006)
- EX-10.13 Agreement with Charles Gorodetzky (Filed With SEC on September 1, 2006)
- EX-10.12 Agreement with Donald Jasinski (Filed With SEC on September 1, 2006)
